Literature DB >> 7926758

The v-abl tyrosine kinase negatively regulates NF-kappa B/Rel factors and blocks kappa gene transcription in pre-B lymphocytes.

C A Klug1, S J Gerety, P C Shah, Y Y Chen, N R Rice, N Rosenberg, H Singh.   

Abstract

Transformation of B-lineage precursors by the Abelson murine leukemia virus appears to arrest development at the pre-B stage. Abelson-transformed pre-B cell lines generally retain transcriptionally inactive, unrearranged immunoglobulin kappa alleles. We demonstrate that nontransformed pre-B cells expanded from the mouse bone marrow efficiently transcribe unrearranged kappa alleles. In addition, they contain activated complexes of the NF-kappa B/Rel transcription factor family, in contrast with their Abelson-transformed counterparts. Using conditionally transformed pre-B cell lines, we show that the v-abl viral transforming protein, a tyrosine kinase, blocks germ-line kappa gene transcription and negatively regulates NF-kappa B/Rel activity. An active v-abl kinase specifically inhibits the NF-kappa B/Rel-dependent kappa intron enhancer, which is implicated in promoting both transcription and rearrangement of the kappa locus. v-abl inhibits the activated state of NF-kappa B/Rel complexes in a pre-B cell via a post-translational mechanism that results in increased stability of the inhibitory subunit I kappa B alpha. This analysis suggests a molecular pathway by which v-abl inhibits kappa locus transcription and rearrangement.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926758     DOI: 10.1101/gad.8.6.678

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  25 in total

Review 1.  Regulation of antigen receptor gene assembly in lymphocytes.

Authors:  E M Oltz
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2.

Authors:  C S Duckett; R W Gedrich; M C Gilfillan; C B Thompson
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

3.  Abelson virus transformation prevents TRAIL expression by inhibiting FoxO3a and NF-kappaB.

Authors:  Mary K Wilson; Sarah M McWhirter; Rupesh H Amin; Dan Huang; Mark S Schlissel
Journal:  Mol Cells       Date:  2010-03-04       Impact factor: 5.034

Review 4.  Genetic analysis of transcription factors implicated in B lymphocyte development.

Authors:  H Singh
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

5.  Characterization of COMMD protein-protein interactions in NF-kappaB signalling.

Authors:  Prim de Bie; Bart van de Sluis; Ezra Burstein; Karen J Duran; Ruud Berger; Colin S Duckett; Cisca Wijmenga; Leo W J Klomp
Journal:  Biochem J       Date:  2006-08-15       Impact factor: 3.857

6.  Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines.

Authors:  J Lauring; M S Schlissel
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

7.  4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB.

Authors:  R H Arch; C B Thompson
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

8.  Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation.

Authors:  H C Liou; W C Sha; M L Scott; D Baltimore
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

9.  NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression.

Authors:  Yukio Nakamura; Raelene J Grumont; Steve Gerondakis
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  v-Abl activates c-myc transcription through the E2F site.

Authors:  K K Wong; X Zou; K T Merrell; A J Patel; K B Marcu; S Chellappan; K Calame
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.